Evidence & regulatory context
- Mechanism
- Graphene-oxide/polycaprolactone electrospun hybrid patch; biomaterial device.
- Target
- Not recorded
- Injury models
- Wound
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatWoundSprague-Dawleymaletopical application of patch to the wound
Model: Open abdomen wound with intestinal fistula
The hybrid patch allowed cells to survive in the presence of bacteria and accelerated wound healing in the open abdomen and intestinal fistula model, with no additional organ damage on sub-acute toxicity scoring.
Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.
